Victory Capital Management »

Theravance Biopharma shares owned by Victory Capital Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Victory Capital Management from 13F filings

Historical chart of Victory Capital Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Victory Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Victory Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $241k 14k 17.00
2022-12-31 $1.8M 159k 11.22
2022-09-30 $1.1M 110k 10.14
2022-06-30 $577k 64k 9.07

More positions owned by Victory Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Alphabet Inc Class C cs (GOOG)
Broadcom (AVGO)
Bank of America Corporation (BAC)
Facebook Inc cl a (META)
United Parcel Service (UPS)
Cisco Systems (CSCO)
Visa (V)
NRG Energy (NRG)

View all positions for Victory Capital Management

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors

View all funds holding Theravance Biopharma